当前位置:首页 > 业务领域 > 污泥处理
亚博vip登陆|手机版|首个白血病治疗基因疗法在美获批
时间:2020-10-09 来源:亚博vip官网 浏览量 33610 次

亚博vip官网-us regulators on Wednesday approved the first gene therapy against cancer-a treatment that uses a patients own immune cells to fight leukemia NG a new美国监管当局8月30日批准了针对癌症的第一个基因治疗手段3354。白血病是世界上死亡率最低的疾病之一,开辟了应对白血病的新时代。the treatment is made by Novartis and is called kym riah。这种治疗方法是在诺华开发的,命名为kymriah。

this type of anti-cancer immunotherapy,known as a CAR-T cell therapy,was known by CTL019 until now。癌症的免疫疗法也被称为CAR-T细胞疗法,This Marks the First-ever Car-T cell therapy to be approved anywhere in the world,Novartis Ceo Joseph Jimenez told replement“这种新的治疗方法用于患者自己的T细胞,几乎是个性化的。”kymriah was approved by the us food and drug administration for children and young adult patients up to age 25 with a form of acute lymphoblastic leuke miaKymriah得到美国食品药品监督管理局的批准,被用作化疗25岁以下的急性淋巴性白血病患者。To qualify for treatment,patients must have B- cell precursor all that is refractory,or The patient has relapsed at least twice The F亚博vip登陆DA desccent一份声明称,美国食品和药物管理局将此次批准描述为“历史行为”和“治疗癌症及其他严重或可怕疾病的新方法”。

the treatment is not a pill or a form of chemotherapy,which can weaken the bodys natural defenses。这种化疗手段不用于药剂或化疗,而是增强人体自身的抵抗力。

Instead,it harnesses a patients own immune cells,called T-cells And white blood cells,And trains them to recognise And fight cancantthese re-engineered t-cells are then transf used back into the patient,where they can begin attacking leuke mia。这个改造后的T细胞不会重新输入患者体内,Studies Have Shown that 83 Percent of Patients Responded to the Treatment,Achieving Remission within Three Months,Novartis诺华将于今年晚些时候向欧洲药物管理局提交申请。

亚博vip官网

the price of Kymriah-which is delivered to a patient just once-is $ 475,000,said Bruno stri Gini,CEO of oncology at novary stigneypatients who do not respond to the treatment within the first month would not be expected to pay,he told reporters。他告诉记者,如果化疗在一个月内对患者违宪, the more common treatment for leuke mia-bone marrow transplants-can cost between $ 540,000 and $800,000 the first year is strigingMeanwhile,outside analyses have set a cost-effective price for Kymriah between $ 600,000和$750,000,he added Recognising our“我们知道我们有责任,所以没有把价格定得那么低,”斯蒂格尼说。

亚博vip官网

most patients who fit the criteria for treatment would likely be covered by insurance,Since they are under 25 and would either be on their parents诺娃的发言人回应说,大部分符合条件的患者都超过25岁,因此不会用于父母的保险或政府资助的医疗补助。the treatment was pioneered by Carl June at the university of Pennsylvania。

这种治疗方法是宾夕法尼亚大学的刀吗?开拓琼。its most high-profile patient is Emily white head,now 12。今年12岁的艾米丽?怀特海是这个治疗方法特别熟悉的患者。Sixyears ago,she was the first child to receive what was widely considered a risky treatment。

六年前,艾米丽成为第一个不接受当时社会普遍认为危险的Kymriah化疗的儿童。She has been cancer-free ever since。但是Kymriah治疗了她的癌症。In 2014是美国注册设计CTL 019 AS A Breakthrough Therapy and put the Experimental Immunotherapy Agent on the Fast track to Market Application_亚博vip官网。

本文来源:亚博vip登陆-www.geotecolsas.com

版权所有安庆市亚博vip登陆科技股份有限公司 皖ICP备63318670号-7

公司地址: 安徽省安庆市剑阁县赛人大楼7263号 联系电话:0735-98465711

Copyright © 2018 Corporation,All Rights Reserved.

熊猫生活志熊猫生活志微信公众号
成都鑫华成都鑫华微信公众号